Background
Jade Teakell
Shedding Light on the Dense Matter of C3 ...

This week, we will discuss the role of ApoE in determining the subtypes of C3 Glomerulopathy.

Shedding Light on the Dense Matter of C3 Glomerulopathy
Background
swapnil hiremath
Healing, Hype, or Harm: The NefIgArd trial

This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?

Healing, Hype, or Harm: The NefIgArd trial
Background
Cristina Adriana Popa
PRAECISely Predicting Preeclampsia

This week, we tag along with NephMadness. It will be hard to stay impartial while discussing the role of angiogenic and antiangiogenic factors in severe preeclampsia prognosis.

PRAECISely Predicting Preeclampsia
Background
swapnil hiremath
The Worldwide Shadow of Kidney Disease

This week, during kidney month and NephMadness season, we will discuss the USRDS report as well as the ISN Global Kidney Health Atlas report from 2024.

The Worldwide Shadow of Kidney Disease
Background
swapnil hiremath
The PROTECT-V platform - RENALISM no more?

This week on NephTrials we will discuss the PROTECT-V trial, a platform trial for preventing COVID-19 infections in the vulnerable kidney populations.

The PROTECT-V platform - RENALISM no more?

ASN

The President of the ASN (@POTASN) is doing a Twitter chat, #AskASN

Tonight at 9pm Eastern Dr. Himmelfarb will be doing an hour chat.

Hashtag: #askASN.

Topics

Topic Zero- What is your favorite ASN memory?

Topic One: What does ASN mean to you?

Topic One: Why did you want to serve as ASN President?

Topic Two: What is ASN doing for the #NephWorkForce?

Topic Two: Why did the Match Task Force and the Council vote for the "all-in approach" to the Match? What does that mean?

Topic Three: Why are you on Twitter? What are you hoping to accomplish?

Topic Four: How has nephrology changed since you were a fellow?

Topic Four: How old are you? What color was your Burton Rose?

Topic Five: What does the ASN of 2025 look like?